Skip to main content

Table 2 Characteristics of the study population

From: Retrospective study of Dana Farber Consortium Protocol in newly diagnosed Egyptian adolescents and young adults with acute lymphoblastic leukemia: Tanta experience

Variables

Median

Range

Age (years)

28

18–39

Hemoglobin (g/dl)

9

5–14

Total leucocytic count x109/L

14

1–138

Platelets x109/L

60

8–253

Bone marrow blast (%)

73

22–96

Variables

Number (%)

Sex

Male

28 (68.29%)

Female

13 (31.71%)

Immunophenotyping

B-ALL

30 (73.17%)

T-ALL

11 (26.83%)

Cytogenetics

Normal

27 (65.85%)

Abnormal

14 (34.15%)

Philadelphia chromosome

Positive

8 (19.51%)

Negative

33 (80.49%)